<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Angioni R</submitter><funding>Fondazione Città della Speranza</funding><pagination>101266</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10694673</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(11)</volume><pubmed_abstract>The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has fueled the COVID-19 pandemic with its enduring medical and socioeconomic challenges because of subsequent waves and long-term consequences of great concern. Here, we chart the molecular basis of COVID-19 pathogenesis by analyzing patients' immune responses at single-cell resolution across disease course and severity. This approach confirms cell subpopulation-specific dysregulation in COVID-19 across disease course and severity and identifies a severity-associated activation of the receptor for advanced glycation endproducts (RAGE) pathway in monocytes. In vitro THP1-based experiments indicate that monocytes bind the SARS-CoV-2 S1-receptor binding domain (RBD) via RAGE, pointing to RAGE-Spike interaction enabling monocyte infection. Thus, our results demonstrate that RAGE is a functional receptor of SARS-CoV-2 contributing to COVID-19 severity.</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity.</pubmed_title><pmcid>PMC10694673</pmcid><funding_grant_id>20/02CoV</funding_grant_id><pubmed_authors>Viola A</pubmed_authors><pubmed_authors>Pasqualato S</pubmed_authors><pubmed_authors>Buratto D</pubmed_authors><pubmed_authors>Elli F</pubmed_authors><pubmed_authors>Rotta L</pubmed_authors><pubmed_authors>Scardua A</pubmed_authors><pubmed_authors>Zonta F</pubmed_authors><pubmed_authors>Bonfanti M</pubmed_authors><pubmed_authors>Savino A</pubmed_authors><pubmed_authors>Cattelan AM</pubmed_authors><pubmed_authors>Caporale N</pubmed_authors><pubmed_authors>Ghezzi S</pubmed_authors><pubmed_authors>Ferrari P</pubmed_authors><pubmed_authors>Molon B</pubmed_authors><pubmed_authors>Putaggio C</pubmed_authors><pubmed_authors>Sanchez-Rodriguez R</pubmed_authors><pubmed_authors>Ricciardelli E</pubmed_authors><pubmed_authors>Pagani I</pubmed_authors><pubmed_authors>Bertoldi N</pubmed_authors><pubmed_authors>Weber J</pubmed_authors><pubmed_authors>Villa CE</pubmed_authors><pubmed_authors>Munari F</pubmed_authors><pubmed_authors>Vicenzi E</pubmed_authors><pubmed_authors>Zanon C</pubmed_authors><pubmed_authors>Iorio F</pubmed_authors><pubmed_authors>Angioni R</pubmed_authors><pubmed_authors>Cecatiello V</pubmed_authors><pubmed_authors>Vannini A</pubmed_authors><pubmed_authors>Testa G</pubmed_authors></additional><is_claimable>false</is_claimable><name>RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity.</name><description>The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has fueled the COVID-19 pandemic with its enduring medical and socioeconomic challenges because of subsequent waves and long-term consequences of great concern. Here, we chart the molecular basis of COVID-19 pathogenesis by analyzing patients' immune responses at single-cell resolution across disease course and severity. This approach confirms cell subpopulation-specific dysregulation in COVID-19 across disease course and severity and identifies a severity-associated activation of the receptor for advanced glycation endproducts (RAGE) pathway in monocytes. In vitro THP1-based experiments indicate that monocytes bind the SARS-CoV-2 S1-receptor binding domain (RBD) via RAGE, pointing to RAGE-Spike interaction enabling monocyte infection. Thus, our results demonstrate that RAGE is a functional receptor of SARS-CoV-2 contributing to COVID-19 severity.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-05-28T08:59:55.83Z</modification><creation>2025-02-19T04:25:41.579Z</creation></dates><accession>S-EPMC10694673</accession><cross_references><pubmed>37944530</pubmed><doi>10.1016/j.xcrm.2023.101266</doi></cross_references></HashMap>